Back to CVE records
Medium 6.3Published Aug 6, 2026

CVE-2026-19038MonomythDevelopment la-forge-mcp screenshot_element Tool index.ts screenshotElement path traversal

Updated under an hour ago ()

Does this affect you?

It affects MonomythDevelopment la-forge-mcp. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A security vulnerability has been detected in MonomythDevelopment la-forge-mcp 1.0.0. This issue affects the function screenshotElement of the file src/index.ts of the component screenshot_element Tool. Such manipulation of the argument output_name leads to path traversal. The attack can be executed remotely. Upgrading to version 1.1.1 is capable of addressing this issue. The name of the patch is 1102172c9adec4a619e241efd6bfb74f5b1f4332. Upgrading the affected component is advised. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.

CVSS
6.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L/E:P/RL:O/RC:C
Weakness (CWE)
CWE-22
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Aug 6, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
MonomythDevelopment la-forge-mcp
monomythdevelopment:la-forge-mcp
1.0.0; 1.1.1 not affected
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • issue-tracking
  • issue-tracking
  • patch
  • patch
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.